Happy New Year! I am thrilled to start off 2012 by sharing some really exciting news with you. We have received FDA approval for the mySentry™ Remote Glucose Monitor, the first product of its kind that allows parents and caregivers to monitor the MiniMed Paradigm® REAL-Time Revel™ System from another room.
We know that many of you d-moms, d-dads and other loved ones spend a lot of tiresome nights checking glucose levels late at night and in the wee hours of the morning. With mySentry at your bedside you can see the following at-a-glance on a color screen while your child sleeps in his/her own room:
- Real-time glucose values.
- A snapshot of glucose trends through CGM graphs and up or down trend arrows.
- Insulin pump information such as amount of insulin remaining and time until the next glucose sensor calibration.
In addition, mySentry allows you to remotely see and hear all the alerts and alarms available on the Paradigm Revel insulin pump. So, for example, you could be alerted through a predictive alarm in the middle of the night if your child’s glucose levels are falling, allowing you to take action to prevent a scary episode of hypoglycemia.
Even with the mySentry monitor, it is still necessary to monitor your blood glucose independently, and all therapy adjustments should be based on measurements obtained using a blood glucose meter. But we hope that this product will help parents and loved ones like you to rest a little bit easier.
I remember back in the Spring at the Diabetes Advocate Forum talking to Meri Schumacher about her life as the mom to four wonderful boys, three of whom live with type 1 diabetes. Looking at the worry on her face was hard (it always is), but talking to her also made me all the more driven to get mySentry to market. Because I believe this will help give parents some much-needed peace of mind, especially at night.
Talking with Meri and the others at that forum also made me very excited about what’s next here at Medtronic. You see, for us, this is just the beginning. mySentry actually marks our first step in a new medical device category of Connected Care products that provide people with diabetes and their caregivers with convenient options to access their diabetes health information remotely.
Our vision is to make it easy and convenient for you to better access the data and insights captured by our integrated insulin pump and continuous glucose monitoring system (CGM) so that you can more proactively manage you/your loved ones’ diabetes. I am so excited to be working with a great team to bring these kinds of products to you and look for your feedback along the way.
For more information about mySentry you can visit www.medtronicdiabetes.com/mysentry.
IMPORTANT SAFETY INFORMATION
The real-time glucose values provided by the mySentry monitor, as received from the Paradigm REAL-Time Revel insulin pump, are not intended to be used directly for making therapy adjustments. Rather, they provide an indication that may require a confirmation fingerstick measurement. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not based on the value displayed by the monitor or Paradigm REAL-Time Revel insulin pump.
Once you turn off an alarm on the mySentry monitor, you need to attend to the alarm on the pump itself. You cannot respond to pump alarms directly through the mySentry monitor.
Failure to monitor your blood glucose independently of the real-time glucose values provided by the mySentry monitor, as received from the Paradigm REAL-Time Revel insulin pump, may result in hyperglycemia or hypoglycemia and significant physical injury, including death.
Transmission of all data or alarms cannot be guaranteed with the mySentry system.
Please visit www.medtronicdiabetes.com/about/safety.html for complete details.
Please visit MedtronicDiabetes.com/isi for complete safety information.
Tags: connected care
, continuous glucose monitoring
, insulin pump